Wednesday, July 17, 2024
7:00pm Eastern/6:00pm Central/5:00pm Mountain/4:00pm Pacific
The AHNS Cutaneous Cancer Section cordially welcomes you to join us for an up-to-date, evidence-based management of locally advanced Merkel cell carcinoma of the head and neck.
Moderator:
Brittny Tillman, MD – Head & Neck Surgeon, UT Southwestern Medical Center
Panelists:
- Sydney Ch’ng, MBBS, PhD – Head & Neck Surgeon, Melanoma Institute Australia & Chris O’Brien Lifehouse Cancer Ctr., University of Sydney
- Michael Wong, MD PhD – Medical Oncologist, MD Anderson Cancer Center
- Evan Wuthrick, MD – Radiation Oncologist, Moffitt Cancer Center
Objectives:
We aim to enhance our attendees’ knowledge base regarding evidence-based management of MCC in the adjuvant setting through the following objectives.
- Objective 1: Appraise the approach and current evidence for the application of SLNBx and management of regional nodal basins following a positive SLNB.
- Objective 2: Articulate the role of radiation to the cervical nodal basins for regionally metastatic or positive SLNB
- Objective 3: Review clinical trials evaluating adjuvant post-operative immunotherapy for regionally metastatic MCC.
